Cerebral vein thrombosis and prothrombin gene (G20210A) mutation

Clinical Neurology and Neurosurgery

Volumn 103, Issue 3, 2001, Pages 191-193

  Heckmann, J G ^a   Tomandl, B ^a   Erbguth, F ^a   Neidhardt, B ^a   Zingsem, H ^a   Neundorfer B ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cerebral vein thrombosis; Coagulopathy; Prothrombin gene mutation G2021A; Thrombotic factors

Indexed keywords

COUMARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN; VALPROIC ACID;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN ANGIOGRAPHY; BRAIN VEIN; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EPILEPSY; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PREGNANCY; RISK; SAGITTAL SINUS THROMBOSIS;

ADULT; AGE FACTORS; AGED; BLOOD COAGULATION DISORDERS; CEREBRAL VEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRACRANIAL THROMBOSIS; MUTATION; PROTHROMBIN; VALPROIC ACID; VENOUS THROMBOSIS;

EID: 0034867649     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-8467(01)00127-5     Document Type: Article

References (21)

1. Cerebral venous thrombosis: diagnosis and management
2. Cerebral venous and sinus thrombosis: an update
3. Prothrombin gene G20210-A transition is a risk factor for cerebral venous thrombosis
4. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
5. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
6. Frequency of the 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene in 35 cases of cerebral venous thrombosis
7. Superior sagittal sinus thrombosis in a patient heterozygous for the novel 20210 A allele of the prothrombin gene
8. Cerebral vein thrombosis not related to use of oral contraceptives in a 7-year-old child carrier of the prothrombin 20210A allele
9. Familial thrombophilia and the prothrombin 20210A mutation: association with increased thrombin generation and unusual thrombosis
10. Cerebral venous sinus thrombosis associated with 20210A mutation of the prothrombin gene
11. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A)
12. Cerebral venous thrombosis and the G20210A mutation of factor II
13. Prothrombin gene variant (G20210A) in a patient with cerebral venous thrombosis
14. Coincidence of factor V Leiden mutation and mutation in the prothrombin gene at position 20210 in a patient with puerperal cerebral venous thrombosis
15. The prothrombin G20210A mutation-a common cause of thrombophilia?
16. Blood coagulation
17. Drug-induced platelet destruction
18. Multiorgan dysfunction and disseminated intravascular coagulation inchild receiving lamotrigine and vaplproic acid
19. Valproic acid-induced placental and teratogenic effects in rats
20. Disseminated intravascular coagulation in an epileptic infant under the treatment with sodium valpoate
21. Hypothesized interaction between valproic acid and warfarin